A major discovery in cancer research is arising with the use of VHH fragments to re-engage dysfunctional p53. This vital cancer inhibitor protein is frequently disabled in many forms of malignancies, resulting https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research